Article Versions Notes

Eisenmann ED, Stromatt JC, Fobare S, Huang KM, Buelow DR, Orwick S, Jeon JY, Weber RH, Larsen B, Mims AS, et al. TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers. 2023; 15(1):29. https://doi.org/10.3390/cancers15010029

Eisenmann, Eric D., Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick, Jae Yoon Jeon, Robert H. Weber, Bill Larsen, Alice S. Mims, and et al. 2023. "TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion" Cancers 15, no. 1: 29. https://doi.org/10.3390/cancers15010029

Eisenmann, E. D., Stromatt, J. C., Fobare, S., Huang, K. M., Buelow, D. R., Orwick, S., Jeon, J. Y., Weber, R. H., Larsen, B., Mims, A. S., Hertlein, E., Byrd, J. C., & Baker, S. D. (2023). TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers, 15(1), 29. https://doi.org/10.3390/cancers15010029